| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.3 |